title: Recombinant Nonstructural 3 Protein, rNS3, of Hepatitis C Virus Along With Recombinant GP96 Induce IL-12, TNFα and α5integrin Expression in Antigen Presenting Cells.
abstract: BACKGROUND
  Hepatitis C virus (HCV) infection is the main cause of chronic liver disease and to date there has been no vaccine development to prevent this infection. Among non-structural HCV proteins, NS3 protein is an excellent goal for a therapeutic vaccine, due to its large size and less variation in conserved regions. The immunogenic properties of heat shock proteins (HSPs) for instance GP96 have prompted investigations into their function as strong adjuvant to improve innate and adaptive immunity.
  
  
  OBJECTIVE
  The aim of this study was to examine additive effects of recombinant GP96 (rGP96) fragments accompanied by rNS3 on expression levels of α5integrin and pro-inflammatory cytokines, IL-12 and TNFα, in Antigen Presenting Cells (APCs).
  
  
  METHODS
  Recombinant viral proteins (rNS3 and rRGD-NS3), N-terminal and C-terminal fragments of GP96 were produced and purified from E. coli in order to treat the cells; mouse spleen Dendritic Cells (DCs) and THP-1 macrophages.
  
  
  RESULTS
  Our results showed that rNT-GP96 alone significantly increases the expression level of IL-12, TNFα and α5integrin in THP-1 macrophages and DCs, while IL-12 and TNFα expression levels were unaffected by either rNS3 or rRGD-NS3. Interestingly, the co-addition of these recombinant proteins with rNT-GP96 increased IL-12, TNFα and α5integrin expression. Pearson Correlation showed a direct association between α5integrin with IL-12 and TNF-α expression.
  
  
  CONCLUSIONS
  we have highlighted the role of rNS3 plus rNT-GP96 mediated by α5integrin in producing IL-12 and TNFα. It can be suggested that rNT-GP96 could enhance immunity characteristic of rNS3 protein via production of pro-inflammatory cytokines.
authors.affiliation: Recombinant Proteins Lab, Biochemistry Department, Medical School, Shiraz University of Medical Sciences, Shiraz, IR Iran.
authors.forename: Mohammad Reza
authors.initials: MR
authors.lastname: Hajizadeh
authors.forename: Pooneh
authors.initials: P
authors.lastname: Mokarram
authors.forename: Eskandar
authors.initials: E
authors.lastname: Kamali Sarvestani
authors.forename: Azam
authors.initials: A
authors.lastname: Bolhassani
authors.forename: Zohreh
authors.initials: Z
authors.lastname: Mostafavi Pour
keywords: Cytokines; Heat- Shock Proteins; Hepatitis C
references.citation: Genome Biol. 2007;8(5):215
references.pmid: 17543136
references.citation: Clin Infect Dis. 2012 Jul;55 Suppl 1:S25-32
references.pmid: 22715210
references.citation: BMC Bioinformatics. 2006 Feb 22;7:85
references.pmid: 16504059
references.citation: J Immunol. 2005 Jan 1;174(1):195-204
references.pmid: 15611241
references.citation: Hepatobiliary Pancreat Dis Int. 2010 Aug;9(4):361-5
references.pmid: 20688598
references.citation: Virol J. 2010 Mar 24;7:69
references.pmid: 20331907
references.citation: Protein Expr Purif. 2006 Nov;50(1):43-8
references.pmid: 16889980
references.citation: Int J Med Sci. 2006;3(2):29-34
references.pmid: 16614739
references.citation: Clin Infect Dis. 2012 Jul;55 Suppl 1:S10-5
references.pmid: 22715208
references.citation: Biomaterials. 2010 Oct;31(29):7444-54
references.pmid: 20637504
references.citation: Vaccine. 2008 Jun 19;26(26):3362-70
references.pmid: 18471945
references.citation: Dtsch Arztebl Int. 2012 May;109(19):352-8
references.pmid: 22675406
references.citation: J Innate Immun. 2009;1(1):4-17
references.pmid: 20375562
references.citation: J Hepatol. 2009 Sep;51(3):520-7
references.pmid: 19596480
references.citation: Nature. 2005 Aug 18;436(7053):946-52
references.pmid: 16107834
references.citation: Scand J Immunol. 2012 Jan;75(1):27-37
references.pmid: 21916914
references.citation: Cancer J. 2010 Jul-Aug;16(4):382-91
references.pmid: 20693851
references.citation: J Leukoc Biol. 2009 Jun;85(6):905-10
references.pmid: 19276179
references.citation: Mol Cancer Res. 2011 Jun;9(6):702-11
references.pmid: 21536688
references.citation: J Viral Hepat. 2004 Jan;11(1):18-26
references.pmid: 14738554
references.citation: Biochem Biophys Res Commun. 2006 Jun 2;344(2):581-7
references.pmid: 16630554
references.citation: Arch Virol. 2012 Oct;157(10):1959-65
references.pmid: 22695769
references.citation: Nat Rev Microbiol. 2007 Jun;5(6):453-63
references.pmid: 17487147
references.citation: Expert Rev Vaccines. 2008 Oct;7(8):1185-99
references.pmid: 18844593
references.citation: Indian J Med Res. 2009 Nov;130(5):533-41
references.pmid: 20090101
references.citation: Curr Pharm Des. 2008;14(17):1646-54
references.pmid: 18673187
references.citation: Iran J Immunol. 2010 Sep;7(3):177-85
references.pmid: 20876988
references.citation: Sheng Wu Gong Cheng Xue Bao. 2011 May;27(5):704-11
references.pmid: 21845836
references.citation: J Immunol Methods. 2004 Apr;287(1-2):67-77
references.pmid: 15099756
references.citation: F1000 Biol Rep. 2012;4:5
references.pmid: 22403588